Institution profile

一般社団法人ReM medical ReM CLINIC Ginza

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2605046 +8

Location

Prefecture
Tokyo
Address
中央区銀座5丁目10番2号 GINZA MISS PARIS 2階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • 再生医療安全推進委員会 特定認定再生医療等委員会
  • 一般社団法人 再生医療安全推進委員会
  • +1

Public score

66.8/ 100

A · Review level
25.0 / 30
B · Technologies
26.5 / 35
C · Coverage
10.7 / 25
D · Class I / II technologies
4.6 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 66.8
Public score →100

Registered technologies (9)

Stem cells (all sources) 2
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
膝関節症に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Adipose-derived stem cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
膝関節症に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
NK and immune cells 7
Registered technologies · Japanese originalTechnology areasPlan classification
悪性腫瘍に対するNK細胞療法NK and immune cellsClass III
悪性腫瘍に対する自家樹状細胞ワクチン療法NK and immune cellsClass III
悪性腫瘍に対する免疫細胞(NK細胞、γδT細胞、CD8陽性細胞、CD4陽性細胞を含む)治療(生物応答修飾剤活性化細胞障害性リンパ球療法:BAK療法)NK and immune cellsClass III
樹状細胞ワクチン個別化標的療法(DC-iPT療法:Dendric Cell Individualized Precision Targeting Therapy)(皮下)NK and immune cellsClass III
αβT細胞療法NK and immune cellsClass III
NK細胞免疫監視強化療法(NK-IST療法:NK IMMUNE SURVEILLANCE THERAPY)NK and immune cellsClass III
樹状細胞ワクチン個別化標的療法(DC-iPT療法:Dendric Cell Individualized Precision Targeting Therapy)NK and immune cellsClass III
Joints and musculoskeletal 1
Registered technologies · Japanese originalTechnology areasPlan classification
膝関節症に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • 再生医療安全推進委員会 特定認定再生医療等委員会
  • 一般社団法人 再生医療安全推進委員会
  • NPO法人抜苦ねっと認定再生医療等委員会

Public document number

  • 01C2605046
  • 01C2605047
  • 01C2605005
  • 01C2601043
  • 01C2601044
  • 01C2601045
  • 03C2503035
  • 02C2505041
  • 02C2505042
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
膝関節症に対する自己脂肪由来幹細胞による治療Class IIJSCSF再生医療等委員会01C2605046
自己脂肪由来幹細胞を用いた慢性疼痛の治療Class IIJSCSF再生医療等委員会01C2605047
樹状細胞ワクチン個別化標的療法(DC-iPT療法:Dendric Cell Individualized Precision Targeting Therapy)(皮下)Class III再生医療安全推進委員会 特定認定再生医療等委員会01C2605005
αβT細胞療法Class III一般社団法人 再生医療安全推進委員会01C2601043
NK細胞免疫監視強化療法(NK-IST療法:NK IMMUNE SURVEILLANCE THERAPY)Class III一般社団法人 再生医療安全推進委員会01C2601044
樹状細胞ワクチン個別化標的療法(DC-iPT療法:Dendric Cell Individualized Precision Targeting Therapy)Class III一般社団法人 再生医療安全推進委員会01C2601045
悪性腫瘍に対するNK細胞療法Class IIINPO法人抜苦ねっと認定再生医療等委員会03C2503035
悪性腫瘍に対する免疫細胞(NK細胞、γδT細胞、CD8陽性細胞、CD4陽性細胞を含む)治療(生物応答修飾剤活性化細胞障害性リンパ球療法:BAK療法)Class IIINPO法人抜苦ねっと認定再生医療等委員会02C2505041
悪性腫瘍に対する自家樹状細胞ワクチン療法Class IIINPO法人抜苦ねっと認定再生医療等委員会02C2505042

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor